• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽聚糖途径:还有更多!

Peptidoglycan pathways: there are still more!

作者信息

Helal Ahmed M, Sayed Ahmed M, Omara Mariam, Elsebaei Mohamed M, Mayhoub Abdelrahman S

机构信息

Department of Pharmaceutical Organic Chemistry, College of Pharmacy, Al-Azhar University Cairo 11884 Egypt

University of Science and Technology, Zewail City of Science and Technology Giza Egypt.

出版信息

RSC Adv. 2019 Sep 9;9(48):28171-28185. doi: 10.1039/c9ra04518j. eCollection 2019 Sep 3.

DOI:10.1039/c9ra04518j
PMID:35530449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9071014/
Abstract

The discovery of 3 and 4 generations of currently existing classes of antibiotics has not hindered bacterial resistance, which is escalating at an alarming global level. This review follows WHO recommendations through implementing new criteria for newly discovered antibiotics. These recommendations focus on abandoning old scaffolds and hitting new targets. In light of these recommendations, this review discusses seven bacterial proteins that no commercial antibiotics have targeted yet, alongside their reported chemical scaffolds.

摘要

目前存在的第三代和第四代抗生素的发现并未阻碍细菌耐药性,全球范围内细菌耐药性正以惊人的速度升级。本综述遵循世界卫生组织的建议,通过为新发现的抗生素实施新的标准。这些建议侧重于摒弃旧的化学结构并寻找新的靶点。鉴于这些建议,本综述讨论了七种尚未有商业抗生素针对的细菌蛋白,以及它们已报道的化学结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/41b6ed0fce2e/c9ra04518j-p5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/cf6d5348391d/c9ra04518j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/52b10c7e1815/c9ra04518j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/7383560072a8/c9ra04518j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/6758550caefe/c9ra04518j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/147679e0d418/c9ra04518j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/4f944e017276/c9ra04518j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/f71422482094/c9ra04518j-p1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/82fdafa21475/c9ra04518j-p2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/3b3b116abc0b/c9ra04518j-p3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/5ee30665fff9/c9ra04518j-p4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/41b6ed0fce2e/c9ra04518j-p5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/cf6d5348391d/c9ra04518j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/52b10c7e1815/c9ra04518j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/7383560072a8/c9ra04518j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/6758550caefe/c9ra04518j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/147679e0d418/c9ra04518j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/4f944e017276/c9ra04518j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/f71422482094/c9ra04518j-p1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/82fdafa21475/c9ra04518j-p2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/3b3b116abc0b/c9ra04518j-p3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/5ee30665fff9/c9ra04518j-p4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac8/9071014/41b6ed0fce2e/c9ra04518j-p5.jpg

相似文献

1
Peptidoglycan pathways: there are still more!肽聚糖途径:还有更多!
RSC Adv. 2019 Sep 9;9(48):28171-28185. doi: 10.1039/c9ra04518j. eCollection 2019 Sep 3.
2
New antibiotics from bacterial natural products.源自细菌天然产物的新型抗生素。
Nat Biotechnol. 2006 Dec;24(12):1541-50. doi: 10.1038/nbt1266.
3
Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.利用海洋天然产物作为平台来解决细菌耐药性和持久性问题。
Acc Chem Res. 2021 Apr 20;54(8):1866-1877. doi: 10.1021/acs.accounts.1c00007. Epub 2021 Mar 18.
4
Unconventional Antibacterials and Adjuvants.非传统抗菌药物和佐剂。
Acc Chem Res. 2021 Feb 16;54(4):917-929. doi: 10.1021/acs.accounts.0c00776. Epub 2021 Jan 29.
5
Novel Targets of Antimicrobial Therapies.新型抗菌治疗靶点。
Microbiol Spectr. 2016 Apr;4(2). doi: 10.1128/microbiolspec.VMBF-0018-2015.
6
Development of Whole-Cell Biosensors for Screening of Peptidoglycan-Targeting Antibiotics in a Gram-Negative Bacterium.用于革兰氏阴性菌中肽聚糖靶向抗生素筛选的全细胞生物传感器的开发。
Appl Environ Microbiol. 2022 Sep 22;88(18):e0084622. doi: 10.1128/aem.00846-22. Epub 2022 Aug 30.
7
The bacterial cell wall as a source of antibacterial targets.作为抗菌靶点来源的细菌细胞壁。
Expert Opin Ther Targets. 2002 Feb;6(1):1-19. doi: 10.1517/14728222.6.1.1.
8
Exploiting current understanding of antibiotic action for discovery of new drugs.利用当前对抗生素作用的认识来发现新药。
Symp Ser Soc Appl Microbiol. 2002(31):4S-15S.
9
Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling.基于进化的抗生素发现:抑制肽聚糖重塑。
Nature. 2020 Feb;578(7796):582-587. doi: 10.1038/s41586-020-1990-9. Epub 2020 Feb 12.
10
Exploiting current understanding of antibiotic action for discovery of new drugs.利用当前对抗生素作用的理解来发现新药。
J Appl Microbiol. 2002;92 Suppl:4S-15S.

引用本文的文献

1
Phenyltriazole-based sulfonamides: novel dual-target agents against MRSA biofilms and resistant pathogens.基于苯基三唑的磺胺类药物:抗耐甲氧西林金黄色葡萄球菌生物膜和耐药病原体的新型双靶点药物。
RSC Adv. 2025 Jun 17;15(22):17186-17202. doi: 10.1039/d5ra02412a. eCollection 2025 May 21.
2
Triazole-functionalized compounds as promising antifungal agents: Synthesis, biological evaluation, and mechanistic insights.作为有前景的抗真菌剂的三唑官能化化合物:合成、生物学评价及机理洞察
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 13. doi: 10.1007/s00210-025-04350-1.
3
Rational design and synthesis of novel phenyltriazole derivatives targeting MRSA cell wall biosynthesis.

本文引用的文献

1
Enzyme structures of the bacterial peptidoglycan and wall teichoic acid biogenesis pathways.细菌肽聚糖和壁磷壁酸生物合成途径的酶结构。
Curr Opin Struct Biol. 2018 Dec;53:45-58. doi: 10.1016/j.sbi.2018.05.002. Epub 2018 Jun 6.
2
Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis.抗菌靶标 MraY 的选择性抑制的结构基础,MraY 是一种参与肽聚糖合成的膜结合酶。
Drug Discov Today. 2018 Jul;23(7):1426-1435. doi: 10.1016/j.drudis.2018.05.020. Epub 2018 May 18.
3
Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens.
靶向耐甲氧西林金黄色葡萄球菌细胞壁生物合成的新型苯基三唑衍生物的合理设计与合成
RSC Adv. 2024 Dec 20;14(54):39977-39994. doi: 10.1039/d4ra07367c. eCollection 2024 Dec 17.
具有广谱抗多药耐药革兰氏阳性细菌病原体活性的烷氧基苯并噻唑。
Eur J Med Chem. 2018 May 25;152:318-328. doi: 10.1016/j.ejmech.2018.04.049. Epub 2018 Apr 25.
4
Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity.叔丁基侧链苯并噻唑:代谢稳定,具有抗生物膜活性。
Eur J Med Chem. 2018 May 10;151:110-120. doi: 10.1016/j.ejmech.2018.03.044. Epub 2018 Mar 19.
5
Towards new antibiotics targeting bacterial transglycosylase: Synthesis of a Lipid II analog as stable transition-state mimic inhibitor.迈向针对细菌转糖基酶的新型抗生素:脂质II类似物作为稳定过渡态模拟抑制剂的合成。
Bioorg Med Chem Lett. 2018 Sep 1;28(16):2708-2712. doi: 10.1016/j.bmcl.2018.03.035. Epub 2018 Mar 15.
6
Potent 1,2,4-Triazino[5,6 b]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis.结核分枝杆菌卡那霉素抗性酶Eis的强效1,2,4-三嗪并[5,6 -b]吲哚-3-硫醚抑制剂
ACS Infect Dis. 2018 Jun 8;4(6):1030-1040. doi: 10.1021/acsinfecdis.8b00074. Epub 2018 Mar 30.
7
GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.GlcNAc-1-P-转移酶-衣霉素复合物结构揭示了抑制 N-糖基化的基础。
Nat Struct Mol Biol. 2018 Mar;25(3):217-224. doi: 10.1038/s41594-018-0031-y. Epub 2018 Feb 19.
8
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).含炔基的苯基噻唑:对耐甲氧西林金黄色葡萄球菌(MRSA)有效的全身活性抗菌剂。
Eur J Med Chem. 2018 Mar 25;148:195-209. doi: 10.1016/j.ejmech.2018.02.031. Epub 2018 Feb 12.
9
Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine.通过抗生素 D-环丝氨酸的磷酸化形式抑制 D-Ala:D-Ala 连接酶。
Nat Commun. 2017 Dec 5;8(1):1939. doi: 10.1038/s41467-017-02118-7.
10
Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability.带有恶二唑连接基的联苯噻唑类抗生素:一种改善理化性质和口服生物利用度的方法。
Eur J Med Chem. 2018 Jan 1;143:1448-1456. doi: 10.1016/j.ejmech.2017.10.048. Epub 2017 Oct 19.